Balchem (BCPC) Expected to Announce Quarterly Earnings on Friday

Balchem (NASDAQ:BCPC) will likely be posting its Q2 2025 quarterly earnings results before the market opens on Friday, July 25th. Analysts expect Balchem to post earnings of $1.25 per share and revenue of $250.31 million for the quarter.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 EPS for the quarter, missing the consensus estimate of $1.25 by ($0.03). The firm had revenue of $250.52 million for the quarter, compared to analyst estimates of $245.70 million. Balchem had a return on equity of 12.01% and a net margin of 14.16%. The company’s revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.03 EPS. On average, analysts expect Balchem to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Balchem Stock Up 0.1%

Shares of NASDAQ:BCPC opened at $158.37 on Friday. The company has a market capitalization of $5.17 billion, a PE ratio of 37.98, a P/E/G ratio of 3.41 and a beta of 0.89. The company has a current ratio of 2.44, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18. Balchem has a twelve month low of $145.70 and a twelve month high of $186.03. The firm has a 50 day simple moving average of $163.37 and a 200-day simple moving average of $162.72.

Institutional Trading of Balchem

Several institutional investors have recently modified their holdings of the stock. Advisors Asset Management Inc. purchased a new stake in Balchem in the 1st quarter valued at $27,000. Jones Financial Companies Lllp raised its position in Balchem by 1,768.2% in the 1st quarter. Jones Financial Companies Lllp now owns 822 shares of the basic materials company’s stock valued at $136,000 after purchasing an additional 778 shares during the last quarter. AQR Capital Management LLC raised its position in Balchem by 124.4% in the 1st quarter. AQR Capital Management LLC now owns 5,074 shares of the basic materials company’s stock valued at $842,000 after purchasing an additional 2,813 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Balchem by 9.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 100,860 shares of the basic materials company’s stock valued at $16,743,000 after purchasing an additional 9,118 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its position in Balchem by 53.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 246,883 shares of the basic materials company’s stock valued at $40,983,000 after purchasing an additional 86,132 shares during the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on BCPC shares. HC Wainwright set a $180.00 price objective on shares of Balchem and gave the stock a “buy” rating in a research report on Monday, April 28th. Wall Street Zen downgraded shares of Balchem from a “buy” rating to a “hold” rating in a research report on Wednesday, May 21st.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.